Search

for
Search:

GlossaryEtoposide

chemotherapy drug that inhibits DNA replication in cancer cells

Etoposide, also known as VP-16, is a chemotherapy drug used to treat various types of cancer, including lung cancer, testicular cancer, and certain types of lymphomas. It works by inhibiting the enzyme topoisomerase II, which is essential for DNA replication and cell division, thereby preventing cancer cells from multiplying.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 261 results

research The Role of Platelet-Rich Plasma in the Prevention of Chemotherapy-Induced Alopecia

2 citations , November 2019 in “Skin appendage disorders”

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

research Resolution of Plantar Hyperkeratosis of Pachyonychia Congenita During Chemotherapy for Ewing Sarcoma

2 citations , August 2013 in “British Journal of Dermatology”

Chemotherapy improved a girl's painful foot condition linked to pachyonychia congenita.

research Vitamin D3 and Chemotherapy-Induced Alopecia

11 citations , June 1996 in “Nutrition”

Vitamin D3 may prevent hair loss from chemotherapy, but side effects and cancer cell protection are concerns.

research Mon-323 Metastatic Adrenocortical Carcinoma Presenting With Mixed Cushing's And Virilization Syndrome Along With Bilateral Pulmonary Emboli

April 2019 in “Journal of the Endocrine Society”

Rapid virilization should be checked for possible ovarian or adrenal cancer.

research A Soy-Derived Immunostimulating Peptide Inhibits Etoposide-Induced Alopecia in Neonatal Rats

17 citations , March 2004 in “Journal of Investigative Dermatology”

Soymetide-4 from soy can prevent hair loss caused by a cancer drug in rats.

View more "etoposide" in research →

Community Join

0 / 0 results

— no results